Anna Dahlgren

Title: Anna Dahlgren: Innovator in Transdermal Drug Delivery Systems

Introduction

Anna Dahlgren is a prominent inventor based in Uppsala, Sweden. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of transdermal drug delivery systems. With a total of 4 patents to her name, Dahlgren is recognized for her innovative approaches to drug administration.

Latest Patents

Among her latest patents is a transdermal drug administration device. This device comprises a drug delivery element that defines a contact surface for application against a patient's skin. The drug delivery element includes a sustained-release pharmaceutical composition, which consists of a network of carrier material with high mechanical strength and an active pharmaceutical ingredient. The active ingredient is co-formedly interspersed within the pores of the solid, continuous network of the carrier material.

Another notable patent is for an abuse-resistant formula. This sustained-release pharmaceutical composition features a solid, continuous network that includes an excipient with high mechanical strength. The network also contains pores, within which a mixture of an active ingredient and a film-forming agent is interspersed. The unique formation of these pores occurs during the production of the composition. These innovations are particularly useful as abuse-resistant formulations for opioid analgesics, which are essential in treating chronic pain.

Career Highlights

Dahlgren is currently associated with Emplicure AB, where she continues to advance her research and development efforts in pharmaceutical formulations. Her work has garnered attention for its potential to improve patient outcomes through innovative drug delivery methods.

Collaborations

Throughout her career, Anna Dahlgren has collaborated with notable colleagues, including Susanne Bredenberg and Anders Sågström. These partnerships have contributed to the success of her projects and the advancement of pharmaceutical technology.

Conclusion

Anna Dahlgren stands out as a leading inventor in the field of transdermal drug delivery systems. Her innovative patents and contributions to pharmaceutical technology highlight her commitment to improving healthcare solutions.